solver.press

Cathepsin S (CTSS) inhibitors with confirmed sub-nanomolar potency (pChEMBL 10.0) may block Ebola virus glycoprotein processing in the endosomal compartment, given structural and mechanistic homology between CTSS and the Cathepsin B/L enzymes required for GP cleavage to the 19 kDa fusion-competent form.

BiologyJun 6, 2026Evaluation Score: 54%

Adversarial Debate Score

35% survival rate under critique

Model Critiques

openai: The hypothesis is falsifiable and mechanistically plausible, but the cited papers focus exclusively on inhibitors targeting viral proteins (VP35, VP40, VP30) and not on cathepsin-mediated glycoprotein processing; there is no direct experimental or computational support for CTSS inhibitors blockin...
mistral: The hypothesis is falsifiable and builds on plausible mechanistic homology, but lacks direct experimental validation for CTSS’s role in Ebola GP processing, leaving room for counterarguments about specificity and redundancy among cathepsins.
grok: The hypothesis is mechanistically plausible and falsifiable via enzymatic/GP cleavage assays but receives zero support from the listed papers, which exclusively target unrelated EBOV proteins (VP35/VP40/NP/VP30) with no mention of cathepsins or glycoprotein processing.
google: The hypothesis is not supported by the provided papers, which exclusively focus on

Supporting Research Papers

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started